The bill establishes the Neurofibromatosis Disease Grant Program within the Florida Department of Health, aimed at advancing research and finding cures for neurofibromatosis. It mandates the awarding of grants, subject to an annual appropriation of $5 million by the Legislature, for scientific and clinical research focused on new diagnostics, treatments, and cures. Eligible applicants include universities and established research institutes in Florida, with a preference for proposals that promote collaboration among institutions and researchers. The program will utilize a competitive, peer-reviewed process to ensure objectivity and high-quality evaluations of grant applications.

Additionally, the bill outlines the responsibilities of the Rare Disease Advisory Council and peer review panels, which will review grant applications based on scientific merit and establish priority scores for funding recommendations. It emphasizes the importance of ethical conduct and conflict of interest policies for council and panel members. Furthermore, it allows for any unspent appropriated funds to be carried forward for up to five years, ensuring that committed resources can be utilized effectively. The act is set to take effect on July 1, 2026.